Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to -$4.3 million.

  • Krystal Biotech's Cash from Investing Activities rose 8751.46% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$153.4 million, marking a year-over-year decrease of 7073.74%. This contributed to the annual value of -$163.4 million for FY2024, which is 29777.71% down from last year.
  • Latest data reveals that Krystal Biotech reported Cash from Investing Activities of -$4.3 million as of Q3 2025, which was up 8751.46% from -$10.5 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Cash from Investing Activities registered a high of $105.2 million during Q3 2023, and its lowest value of -$126.5 million during Q4 2021.
  • Over the past 5 years, Krystal Biotech's median Cash from Investing Activities value was -$19.4 million (recorded in 2024), while the average stood at -$25.9 million.
  • In the last 5 years, Krystal Biotech's Cash from Investing Activities crashed by 738433.73% in 2022 and then surged by 81350.47% in 2023.
  • Over the past 5 years, Krystal Biotech's Cash from Investing Activities (Quarter) stood at -$126.5 million in 2021, then surged by 95.88% to -$5.2 million in 2022, then tumbled by 95.08% to -$10.2 million in 2023, then plummeted by 724.59% to -$83.8 million in 2024, then soared by 94.88% to -$4.3 million in 2025.
  • Its Cash from Investing Activities stands at -$4.3 million for Q3 2025, versus -$10.5 million for Q2 2025 and -$54.8 million for Q1 2025.